CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-02 | Patel Sunil Director | Purchase | +1,000 | $95.98 | $96K | 26,359 |
| 2019-08-01 | LAMATTINA JOHN L Director | Option exercise | +2,500 | $32.30 | $81K | 24,784 |
| 2019-08-01 | LAMATTINA JOHN L Director | Shares withheld for taxes | −847 | $95.58 | $81K | 23,937 |
| 2019-08-01 | LAMATTINA JOHN L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,500 | 4,835 | ||
| 2019-07-31 | Sabba Stephen L Director | Sale | −4,091 | $94.45 | $386K | 23,600 |
| 2019-07-31 | HIGGINS JOHN L Chief Executive Officer | Purchase | +1,850 | $95.45 | $177K | 146,749 |
| 2019-07-31 | Aryeh Jason Director | Purchase | +754 | $93.00 | $70K | 65,707 |
| 2019-07-30 | Aryeh Jason Director | Purchase | +3,000 | $100.22 | $301K | 64,953 |
| 2019-07-29 | Aryeh Jason Director | Purchase | +250 | $106.01 | $27K | 61,953 |
| 2019-02-15 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Shares withheld for taxes | −354 | $120.86 | $43K | 16,115 |
| 2019-02-15 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Shares withheld for taxes | −377 | $120.86 | $46K | 15,738 |
| 2019-02-15 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Shares withheld for taxes | −435 | $120.86 | $53K | 15,303 |
| 2019-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −938 | $120.86 | $113K | 124,615 |
| 2019-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −1,246 | $120.86 | $151K | 123,369 |
| 2019-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −642 | $120.86 | $78K | 122,727 |
| 2019-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,918 | $120.86 | $232K | 136,981 |
| 2019-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,689 | $120.86 | $204K | 135,292 |
| 2019-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,310 | $120.86 | $158K | 133,982 |
Page 43 of 43 · 858 trades